Careers article - November 14, 2025
Mikael Dolsten will not seek election to Novo Nordisk’s Board of Directors
On November 13, the day before the company's Extraordinary General Meeting, it was announced that Mikael Dolsten will not seek election to the Board of Directors as otherwise announced in the notice convening the meeting.
Careers article - October 8, 2025
Statens Serum Institut: “We work closely with academic partners to strengthen Denmark’s preparedness”
Sweden's State Epidemiologist, Magnus Gisslén, resigned in August, stating that his former employer has serious problems, including lack of medical expertise in management. He has also compared the agency to its Danish equivalent, Statens Serum Institute (SSI), where "the management consists of leading medical experts and important research is conducted". NLS asked the Executive Vice President (EVP) of SSI, Tyra Grove Krause, about their management and the importance of working closely with academic partners.
Biotech Business - October 2, 2025
Mendus updates clinical strategy and operational focus
“The goal of our clinical strategy is to further broaden the positioning of vididencel in the AML treatment landscape and in CML as a new indication. The execution of this clinical development plan requires operational focus, and we will therefore reduce our R&D activities to what is required to support our clinical programs," says Mendus CEO Erik Manting.
Careers article - September 10, 2025
Novo Nordisk to reduce its workforce by 9,000
Novo Nordisk intends to reduce the global workforce by approximately 9,000 of the 78,400 positions in the company, with around 5,000 reductions expected in Denmark.
Careers article - September 2, 2025
Lund University’s recruitment drive attracts great interest
Over 1,300 people have applied for the 25 positions advertised in Lund University’s largest ever international recruitment drive.
Careers article - August 20, 2025
Sweden’s State Epidemiologist resigns and criticizes the Public Health Agency
Magnus Gisslén took up the position as State Epidemiologist in September 2023 and has now chosen to terminate his employment. In posts on LinkedIn, Gisslén published four videos stating that the Public Health Agency of Sweden has serious problems, including lack of medical expertise in management and poor leadership.